Encompass Health (NYSE:EHC) PT Raised to $95.00

Encompass Health (NYSE:EHC) had its target price lifted by investment analysts at Mizuho from $93.00 to $95.00 in a report released on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Mizuho’s price target would suggest a potential upside of 15.21% from the stock’s previous close.

Several other research analysts have also weighed in on EHC. Barclays upped their price target on Encompass Health from $95.00 to $101.00 and gave the company an “overweight” rating in a research report on Thursday, March 28th. Royal Bank of Canada reissued an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a research report on Friday, February 9th. Stephens reissued an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. Truist Financial upped their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $86.56.

Encompass Health Trading Down 0.3 %

Shares of NYSE EHC opened at $82.46 on Thursday. Encompass Health has a 12 month low of $57.55 and a 12 month high of $85.84. The company has a market cap of $8.26 billion, a price-to-earnings ratio of 22.29, a P/E/G ratio of 1.53 and a beta of 0.94. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The business has a fifty day simple moving average of $78.25 and a 200-day simple moving average of $70.87.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $0.93 by $0.19. The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.27 billion. Encompass Health had a return on equity of 18.48% and a net margin of 7.60%. Encompass Health’s revenue was up 13.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.88 earnings per share. Sell-side analysts predict that Encompass Health will post 3.96 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in EHC. Principal Securities Inc. acquired a new position in shares of Encompass Health during the 4th quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. increased its holdings in shares of Encompass Health by 360.2% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after acquiring an additional 317 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in Encompass Health during the 4th quarter valued at approximately $30,000. GAMMA Investing LLC bought a new stake in Encompass Health during the 4th quarter valued at approximately $33,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in Encompass Health during the 3rd quarter valued at approximately $35,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.